Few population-based data exist on the prevalence of the metabolic syndrome (MS) its components, and its association with subclinical inflammation and insulin resistance among patients newly diagnosed with type 2 diabetes (T2D).
89% of the newly diagnosed T2D patients have the MS, with 90% having elevated waist circumference, blood pressure and blood glucose, and <50% having elevated triglycerides and reduced HDL-cholesterol.
In T2D patients with MS -Elevated C-peptide levels are common* -CRP levels are increased* -the risk of previous cardiovascular disease is high* * as compared to non-MS patients.
We examined the MS according to the International Diabetes Federation (IDF) criteria from 2009 by linkage primary data (waist circumference, fasting blood glucose, and C-reactive protein (CRP)) with variables from the Danish Diabetes Database for Adults (blood pressure and lipids) and a nationwide prescription database (antilipidemic, antihypertensive, and hypoglycemic drugs) as illustrated below.
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